Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | F13A1 | P00488 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10326271 | 0.83 | MTNR1A (0.45) | SMN1; SMN2NPC1RAB9AALDH1A1CA12 | |
| SCHEMBL7865714 | 0.76 | KDM4E (0.53) | ST14KDM4EF13A1SMN1; SMN2NPC1 | |
| SCHEMBL8620792 | 0.75 | HRH4 (0.58) | — | |
| SCHEMBL14467311 | 0.74 | HDAC1 (0.48) | IDO1CNR1TAAR1 | |
| SCHEMBL6682640 | 0.74 | ST14 (0.50) | ST14KDM4EF13A1SMN1; SMN2NPC1 | |
| SCHEMBL9196642 | 0.73 | NOS1 (0.56) | NPC1RAB9AIDO1CYP2D6 | |
| SCHEMBL12401907 | 0.71 | ST14 (0.51) | ST14KDM4EF13A1SMN1; SMN2NPC1 | |
| SCHEMBL20144285 | 0.70 | KDM4E (0.67) | KDM4EF13A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL20911609 | 0.70 | NPC1 (0.53) | KDM4EF13A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL6679010 | 0.70 | ST14 (0.50) | ST14KDM4EF13A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12023303-B2 | System for determining accuracy of serially-connected drug modules in a combinatorial drug delivery device using voltage | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-02 | — | — | US | disclosed |
| EP-4344695-A2 | COMBINATORIAL DRUG DELIVERY DEVICE | Bristol-Myers Squibb Company (US) | 2024-04-03 | — | — | EP | disclosed |
| US-11944588-B2 | Devices and systems for delivery of combination therapies | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-04-02 | — | — | US | disclosed |
| EP-3790525-B1 | COMBINATORIAL DRUG DELIVERY DEVICE | BRISTOL MYERS SQUIBB CO (US) | 2024-03-20 | — | — | EP | disclosed |
| EP-4054511-B1 | SYSTEM FOR DETERMINING ACCURACY OF SERIALLY-CONNECTED DRUG MODULES IN A COMBINATORIAL DRUG DELIVERY DEVICE USING VOLTAGE | BRISTOL MYERS SQUIBB CO (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-4331556-A2 | DEVICES AND SYSTEMS FOR DELIVERY OF COMBINATION THERAPIES | Bristol-Myers Squibb Company (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-3790524-B1 | DEVICES AND SYSTEMS FOR DELIVERY OF COMBINATION THERAPIES | BRISTOL MYERS SQUIBB CO (US) | 2024-02-28 | — | — | EP | disclosed |
| US-20240058529-A1 | SYSTEM FOR VERIFYING ACCURACY OF SERIALLY-CONNECTED DRUG MODULES IN A COMBINATORIAL DRUG DELIVERY DEVICE | BRISTOL MYERS SQUIBB CO (US) | 2024-02-22 | — | — | US | disclosed |
| US-20240009081-A1 | COMBINATORIAL DRUG DELIVERY DEVICE | BRISTOL MYERS SQUIBB CO (US) | 2024-01-11 | — | — | US | disclosed |
| US-11844927-B2 | System for verifying accuracy of serially-connected drug modules in a combinatorial drug delivery device | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-12-19 | — | — | US | disclosed |
| EP-4245375-A2 | COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT | Bristol-Myers Squibb Company (US) | 2023-09-20 | — | — | EP | disclosed |
| US-20230111786-A1 | COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-04-13 | — | — | US | disclosed |
| US-20230044334-A1 | COMBINATORIAL DRUG DELIVERY DEVICE | BRISTOL MYERS SQUIBB CO (US) | 2023-02-09 | — | — | US | disclosed |
| US-20220395631-A1 | RADIALLY ADJUSTABLE MULTI-CARTRIDGE COMBINATORIAL DRUG DELIVERY DEVICE FOR SUBCUTANEOUS INJECTION | BRISTOL MYERS SQUIBB CO (US) | 2022-12-15 | — | — | US | disclosed |
| US-20220378656-A1 | SYSTEM FOR DETERMINING ACCURACY OF SERIALLY-CONNECTED DRUG MODULES IN A COMBINATORIAL DRUG DELIVERY DEVICE USING VOLTAGE | BRISTOL MYERS SQUIBB CO (US) | 2022-12-01 | — | — | US | disclosed |
| US-20220023531-A1 | DEVICES AND SYSTEMS FOR DELIVERY OF COMBINATION THERAPIES | BRISTOL MYERS SQUIBB CO (US) | 2022-01-27 | — | — | US | disclosed |
| US-20210340250-A1 | COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-11-04 | — | — | US | disclosed |
| US-20210154097-A1 | SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY DEVICE | BRISTOL MYERS SQUIBB CO (US) | 2021-05-27 | — | — | US | disclosed |
| US-20210145696-A1 | COMBINATORIAL DRUG DELIVERY DEVICE | BRISTOL MYERS SQUIBB CO (US) | 2021-05-20 | — | — | US | disclosed |
| US-20130115322-A1 | Therapeutic Compositions and Methods for Treating Cell Dysplasia Using Extracts From Raspberry and Strawberry | THE OHIO STATE UNIVERSITY | 2013-05-09 | — | — | US | disclosed |